Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping
Author:
Funder
Catholic University of the Sacred Heart
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference60 articles.
1. American Thoracic Society Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease;Anonymous;Am. J. Respir. Crit. Care Med.,1995
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease;Pauwels;Am. J. Respir. Crit. Care Med.,2001
3. Evolution of the GOLD documents for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Controversies and questions;Yusen;Am. J. Respir. Crit. Care Med.,2013
4. Reduction of exacerbations by the PDE4 inhibitor roflumilast – the importance of defining different subsets of patients with COPD;Rennard;Respir. Res.,2011
5. Azithromycin for prevention of exacerbations of COPD;Albert;N. Engl. J Med.,2011
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Modelling 30-day hospital readmission after discharge for COPD patients based on electronic health records;npj Primary Care Respiratory Medicine;2023-04-10
2. ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß2 adrenoceptor agonist (MABA) radiolabelled at both functional moieties;Xenobiotica;2023-04-03
3. Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology;Tuberculosis and Respiratory Diseases;2022-10-01
4. “My life is not going to be the same, my health is going to improve”: a cross-sectional qualitative study of patients’ experiences of living with chronic respiratory symptoms and their views on a proposed pulmonary rehabilitation program at Queen Elizabeth Central Hospital, Blantyre, Malawi;Wellcome Open Research;2022-02-25
5. Protocol for a single-centre mixed-method pre–post single-arm feasibility trial of a culturally appropriate 6-week pulmonary rehabilitation programme among adults with functionally limiting chronic respiratory diseases in Malawi;BMJ Open;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3